VAERS 1254218
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN8202
- Staat
- NC
- Alter
- -
- Geschlecht
- F
- Eingang
- 18.07.2021
- Impfdatum
- 28.02.2021
- Beginn
- 28.02.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Symptomtext
she had anaphylactic shock; she was not able to complete the vaccination series; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 28Feb2021 as first dose, single for COVID-19 immunization. Medical history included breast cancer and radiation therapy. The patient's concomitant medications were not reported. On 28Feb2201, 45 minutes later, the patient experienced anaphylactic shock. She went to 5 doctors and all of them did not recommend her to get the 2nd dose. She had the antibody test (164060-SARS - COV 2 antibody IgG) and tested negative. It was reported that she was not able to complete the vaccination series, her doctor advised her to have antibody testing to show that she still developed immunity from the 1st dose. She will travel internationally and she might need to have some proof of vaccination handy. She asked what would be her recourse and if Pfizer could give any recommendations on her situation. The patient underwent lab tests and procedures which included antibody test: negative on an unspecified date in 2021. Seriousness of anaphylactic shock was medically significant. The clinical outcome of the events was unknown. Information about batch/Lot number has been requested.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaphylactic shock
- Hospital-Tage
- -
- Labordaten
- Test Date: 2021; Test Name: Antibody test; Test Result: Negative
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Breast cancer; Radiation therapy
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -